Sobi to present clinical data on Gamifant® at Histiocyte Society 2026 in Rotterdam

STOCKHOLM, Sept. 24, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that new clinical data on Gamifant® (emapalumab) in primary haemophagocytic lymphohistiocytosis (HLH) will be presented at the 2026 Annual Meeting of the Histiocyte Society (HS2026), taking place 26-29 September...